Active-control trials: How would a new agent compare with placebo? A method illustrated with clopidogrel, aspirin, and placebo
- 1 January 2001
- journal article
- research article
- Published by Elsevier BV in American Heart Journal
- Vol. 141 (1), 26-32
- https://doi.org/10.1067/mhj.2001.111262
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Bayesian Design and Analysis of Active Control Clinical TrialsBiometrics, 1999
- One Large, Well-Designed, Multicenter Study as an Alternative to the Usual Fda ParadigmDrug Information Journal, 1999
- When are clinical trials of a given agent vs. placebo no longer appropriate or feasible?Controlled Clinical Trials, 1997
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 1996
- ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarctionThe Lancet, 1995
- Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patientsBMJ, 1994
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- Cardiovascular Risk and Risk Factors in a Randomized Trial of Treatment Based on the Beta-Blocker Oxprenolol: The International Prospective Primary Prevention Study in Hypertension (IPPPSH)Journal Of Hypertension, 1985
- MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party.BMJ, 1985
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985